Jan 30 (Reuters) - Thoma Bravo is exploring a sale of Imprivata, a digital identity software provider for the healthcare industry, according to three people familiar with the matter.
The software-focused private equity investor is working with investment bankers at JPMorgan and Evercore on the sale process for the company, which is currently in its early stages, the sources said.
